Moderna
MRNA
#1461
Rank
A$19.19 B
Marketcap
$48.63
Share price
-2.23%
Change (1 day)
-66.93%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$19.19 Billion

As of March 2025 Moderna has a market cap of A$19.19 Billion. This makes Moderna the world's 1461th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025A$19.19 B-22.7%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Mar 3rd, 2025 the market cap of Moderna was reported to be:

A$18.76 Billion
by Yahoo Finance info icon info icon
A$18.76 Billion
by CompaniesMarketCap info icon info icon
A$18.76 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.14 B-99.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$378.04 B 1,869.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.33 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$51.26 B 167.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$351.02 B 1,729.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$3.82 B-80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
A$647.06 B 3,271.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.78 B-75.07%๐Ÿ‡บ๐Ÿ‡ธ USA